Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders

scientific article

Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S13365-011-0076-8
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s13365-011-0076-8
P932PMC publication ID3374917
P698PubMed publication ID22234543
P5875ResearchGate publication ID221737898

P50authorBen GouauxQ47808885
Virawudh SoontornniyomkijQ56332615
Harry V VintersQ87489627
Eliezer MasliahQ28324209
P2093author name stringDavid J Moore
Ian P Everall
Cristian L Achim
Erick T Tatro
Vadim Gospodarev
Nicole S Yin
P2860cites workOverexpressing the glucocorticoid receptor in forebrain causes an aging-like neuroendocrine phenotype and mild cognitive dysfunctionQ43036350
Prevalence of cognitive disorders differs as a function of age in HIV virus infectionQ44838410
The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.Q45274123
Perceived stress in HIV-infected individuals: physiological and psychological correlatesQ46286400
Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controlsQ46430101
The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load.Q48485626
Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.Q48910182
Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.Q52008026
Serum cortisol and DHEA concentrations during HIV infectionQ73605257
Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046Q80059259
A role for FKBP52 in Tau protein functionQ24298431
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsQ24631745
mTOR signaling: at the crossroads of plasticity, memory and diseaseQ24647655
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentQ28295248
Expression and regulation of the Fkbp5 gene in the adult mouse brainQ28742919
Stress and the brain: from adaptation to diseaseQ29619381
Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stressQ30484846
Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expressionQ30717812
The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.Q33697630
An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adultsQ33917623
Short-term recognition memory impairment is associated with decreased expression of FK506 binding protein 51 in the aged mouse brainQ34080397
Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorderQ34089554
Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in miceQ34132386
The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different culturesQ34556417
The glucocorticoid responses are shaped by molecular chaperonesQ34650079
Brain development under stress: hypotheses of glucocorticoid actions revisitedQ34994021
Organization and function of the FKBP52 and FKBP51 genesQ35165005
Updated research nosology for HIV-associated neurocognitive disordersQ35755761
Stress hormones and human memory function across the lifespanQ35931451
Sex differences in HPA axis responses to stress: a reviewQ36059053
Highly stressed: stressful and traumatic experiences among individuals with HIV/AIDS in the Deep SouthQ37058154
Evolution of HIV dementia with HIV infectionQ37073653
Salivary cortisol as a biomarker in stress researchQ37354499
Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disordersQ37416015
The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disordersQ37533417
FKBP51 regulation of AKT/protein kinase B phosphorylationQ37865924
Steroid up-regulation of FKBP51 and its role in hormone signalingQ37870499
FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.Q40482000
FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior.Q42494154
Hypothalamic-pituitary-adrenal axis function and corticosterone receptor expression in behaviourally characterized young and aged Long-Evans ratsQ42517801
P433issue4
P304page(s)313-322
P577publication date2012-01-11
P1433published inJournal of NeuroVirologyQ6295640
P1476titleIncreased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders
P478volume18

Reverse relations

cites work (P2860)
Q36622848Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers
Q89219004HIV and symptoms of depression are independently associated with impaired glucocorticoid signaling
Q38006721Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51.

Search more.